What Pharmanel Pharmaceuticals does

Pharmanel Pharmaceuticals (legal name ΦΑΡΜΑΝΕΛ Α.Ε.) is a Greek pharmaceutical company headquartered in Attikí, Greece, that develops, manufactures, and supplies prescription and over-the-counter (OTC/ΜΗΣΥΦΑ) pharmaceutical products. Its commercial focus is on generic medicines (γενόσημα) and non-prescription consumer health products distributed through the Greek pharmacy retail channel to end consumers. The product portfolio is marketed under the VIAN brand, with corporate and customer-facing information hosted via the parent group's website (vian.gr) and the contact channel [email protected].

In 2019, Pharmanel was acquired by VIAN (ΒΙΑΝ), a member of the VIANEX Group (Όμιλος ΒΙΑΝΕΞ), a diversified Greek pharmaceutical conglomerate. In 2021, Pharmanel was merged with VIAN within the same group, consolidating the generic and OTC/ΜΗΣΥΦΑ franchise into a single entity operating under the VIAN – Pharmanel trade name. As a result, Pharmanel no longer operates as a standalone legal entity; its functions are now executed within the VIANEX Group structure, and the company is described as having "acquired" operating status. Headcount is reported at 51–100 employees, and the geographic footprint is single-country (Greece).

The business model is B2B2C wholesale distribution of generics and OTC pharmaceuticals to Greek pharmacies, with no publicly disclosed pricing, revenue figures, or product-level cost structure. The company's value proposition centers on providing affordable generic medicines and self-medication products to pharmacy-channel consumers, leveraging the parent group's distribution network, formulation capabilities, and stated intent to add new collaborations and formulations to expand presence domestically and globally.

Name

Pharmanel Pharmaceuticals

Legal name

ΦΑΡΜΑΝΕΛ Α.Ε.

Website

https://pharmanel.gr

Company type

Private

Operating status

Acquired

Headcount range

51–100 employees

Short description

Pharmanel Pharmaceuticals is a Greek company that develops and distributes generic prescription drugs and OTC/ΜΗΣΥΦΑ medicines through the Greek pharmacy retail channel, now operating as a merged entity within the VIANEX Group under the VIAN brand.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Full-Line Pharmaceutical Wholesalers (HLAIAJAA)

Keywords

• Generic pharmaceuticals
• Over-the-counter medications
• Pharmaceutical manufacturing
• Pharmacy distribution
• Prescription medicines

Headquarters

HQ city

Attikí

HQ country

Greece

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels1 record

Core offering

Pharmanel Pharmaceuticals develops, manufactures and supplies generic pharmaceutical products (γενόσημα) and over-the-counter medications (ΜΗΣΥΦΑ/OTC) under the VIAN brand. The company distributes these pharmaceutical products through pharmacy retail channels within Greece as a subsidiary entity of the VIANEX Group, following its 2019 acquisition and 2021 merger with VIAN.

Product overview

Pharmanel Pharmaceuticals operates as a pharmaceutical company under the VIAN brand within the VIANEX Group. Following the 2019 acquisition of PHARMNEL A.E. and the 2021 merger of PHARMNEL with VIAN, the company offers a portfolio of generic pharmaceutical products (generics) and non-prescription medicines (ΜΗΣΥΦΑ/OTC) marketed under the VIAN brand for distribution through pharmacy channels.

Differentiator

Problem solved

Functional benefit

Products and services

• Generic Pharmaceutical Products (γενόσημα) Generic (γενόσημα) prescription pharmaceutical products developed and manufactured by Pharmanel Pharmaceuticals, distributed through pharmacy retail channels in Greece under the VIAN brand as part of the VIANEX Group portfolio.
• Over-the-Counter Medications (ΜΗΣΥΦΑ) Non-prescription, over-the-counter (ΜΗΣΥΦΑ/OTC) self-medication pharmaceutical products developed and supplied by Pharmanel Pharmaceuticals, distributed to pharmacy retail locations in Greece under the VIAN brand.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• VIAN (ΒΙΑΝ) / VIANEX Group (Όμιλος ΒΙΑΝΕΞ)coreOthers · 1 January 2021In 2021, Pharmanel completed its merger with VIAN company of the VIANEX Group, with the purpose of promoting generic products and OTC/ΜΗΣΥΦΑ products in the pharmacy sector. This structural integration combined Pharmanel's portfolio with VIAN's distribution network.
• VIAN (ΒΙΑΝ) / VIANEX Group (Όμιλος ΒΙΑΝΕΞ)coreOthers · 1 January 2019In 2019, VIAN (ΒΙΑΝ) of the VIANEX Group (Όμιλος ΒΙΑΝΕΞ) acquired Pharmanel A.E. pharmaceutical company. This acquisition was part of VIANEX Group's strategy to expand its presence and expertise both domestically and globally.

Recent moves5 records

Expansion highlights2 records

Direct peers

• Help Pharmaceuticals: Greek generics-focused pharmaceutical manufacturer serving the domestic pharmacy channel. Direct domestic peer in the generics segment.
• ELPEN Pharmaceutical: Greek pharmaceutical manufacturer with broad generic and OTC portfolio distributed through Greek pharmacies. Directly comparable to Pharmanel in geography, product mix, and pharmacy-channel go-to-market.
• Demo S.A. Pharmaceuticals: Greek pharmaceutical company producing generic and branded medicines for retail pharmacy distribution. Operates in the same Greek market with overlapping generics and OTC categories.
• Galenica A.E. Greek pharmaceutical company offering generics and consumer health products via pharmacy channels. Comparable domestic competitor in generic and OTC categories.

Broad incumbents

• Teva Pharmaceutical Industries: World's largest generic manufacturer with broad retail-pharmacy distribution across Europe. Operates in the same generic categories as Pharmanel but at significantly larger global scale.
• Sandoz (Novartis): Global leader in generics and biosimilars following separation from Novartis. Competes in the same retail-pharmacy generic and OTC categories at scale across Europe.
• Viatris: Global generics and specialty manufacturer formed via Mylan–Upjohn merger. Sells a broad generics portfolio through European retail pharmacy channels, comparable in product category to Pharmanel.
• Stada Arzneimittel: European-focused generic and consumer healthcare company with strong pharmacy distribution. Comparable in retail-channel generics and OTC consumer health categories.

Regional players

• Alapis S.A. Greek pharmaceutical company historically active in generics and OTC distribution through domestic pharmacies. Domestic market peer, although currently restructured, operating in the same Greek channels.
• Rafa Pharmaceutical Industries: Israeli pharmaceutical manufacturer specializing in generics and OTC products for retail pharmacy distribution. Comparable as a regional generics manufacturer targeting retail pharmacy channels.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/pharmanel-pharmaceuticals

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmanel Pharmaceuticals